Division of Gastroenterology & Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.
National Institute on Drug Abuse, Baltimore, MD, United States.
Dig Liver Dis. 2022 Nov;54(11):1459-1468. doi: 10.1016/j.dld.2022.07.007. Epub 2022 Aug 4.
The COVID-19 pandemic is having substantial impacts on the health status of individuals with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). AUD and ALD have both been impacted throughout the pandemic, with increases in alcohol use during the early stages of the pandemic, reduced access to treatment during the mid-pandemic, and challenges in managing the downstream effects in the post-COVID era. This review will focus on how the COVID-19 pandemic has impacted AUD and ALD epidemiology and access to treatment, and will discuss to address this rising AUD and ALD disease burden.
译文：
COVID-19 大流行对患有酒精使用障碍（AUD）和酒精相关肝病（ALD）的个体的健康状况产生了重大影响。在大流行期间，AUD 和 ALD 都受到了影响，在大流行的早期阶段，酒精使用量增加，在大流行中期，治疗机会减少，以及在后 COVID 时代管理下游影响的挑战。本综述将重点讨论 COVID-19 大流行如何影响 AUD 和 ALD 的流行病学和治疗机会，并讨论如何应对这一不断上升的 AUD 和 ALD 疾病负担。
